State data shows opioid-related deaths have fallen to their lowest levels in a decade, driven by harm reduction efforts and local partnerships.
In an article from the Maryland Reporter, Maryland is seeing significant progress in its fight against the opioid crisis, with opioid-related overdose deaths dropping 57% since their pandemic-era peak. According to a recent analysis by Capital News Service, the state recorded just over 1,000 opioid-related overdose deaths in 2025, down from more than 2,500 in 2020.
The decline can be attributed to expanded access to naloxone (Narcan), fentanyl test strips, substance use treatment programs, and increased investment through Maryland’s Opioid Restitution Fund. Stronger partnerships with local governments and community-based organizations have led frontline overdose prevention and harm reduction efforts. As previously covered by MACo, localized remediation efforts, particularly through local health departments, have been highly responsive to the unique needs of individual communities, which often differ across jurisdictions. Local agencies have swiftly implemented several tactics to put settlement funds to effective use, including but not limited to:
- medication assisted treatment
- crisis intervention and stabilization
- harm reduction services
- linkage to care
- mobile crisis response units
- peer specialists and coordination
- school-based prevention
- recovery housing
- naloxone distribution
From the article:
Maryland continues to show that our partnerships with local communities are invaluable in our efforts to reduce overdoses across the state. We have more work to do—but by working together, we will continue to fight for those seeking recovery, said Gov. Wes Moore in a January press release about the reduction in overdose deaths.
Several counties have reported substantial improvements. Anne Arundel County, for example, saw opioid-related overdose deaths fall by roughly 70% since 2020. Meanwhile, many rural counties reported fewer than 10 overdose deaths last year.
Prevention and harm reduction strategies remain central to the state’s response. Distribution of naloxone and fentanyl test strips has more than doubled since 2020, with the state distributing more than 440,000 naloxone doses last year alone. Innovative programs like Maryland’s Rapid Analysis of Drugs initiative are also helping health officials and local organizations better understand changes in the illicit drug supply and respond in real time.
The state continues to receive funding through opioid-related legal settlements, including more than $90 million recently secured through the Purdue Pharma and Sackler family settlement. Those funds are helping support local prevention, treatment, and recovery efforts across communities. While more work remains, the data signals meaningful progress and demonstrates how coordinated state and local strategies can save lives.
